- Home
- KAR vs DNLI Comparison
KAR vs DNLI Comparison
Compare KAR & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAR
- DNLI
- Stock Information
- Founded
- KAR 2006
- DNLI 2013
- Country
- KAR United States
- DNLI United States
- Employees
- KAR N/A
- DNLI N/A
- Industry
- KAR Retail-Auto Dealers and Gas Stations
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KAR Consumer Discretionary
- DNLI Health Care
- Exchange
- KAR Nasdaq
- DNLI Nasdaq
- Market Cap
- KAR 2.1B
- DNLI 2.1B
- IPO Year
- KAR 2009
- DNLI 2017
- Fundamental
- Price
- KAR $20.13
- DNLI $12.29
- Analyst Decision
- KAR Buy
- DNLI Strong Buy
- Analyst Count
- KAR 5
- DNLI 16
- Target Price
- KAR $22.20
- DNLI $37.57
- AVG Volume (30 Days)
- KAR 912.0K
- DNLI 1.3M
- Earning Date
- KAR 04-30-2025
- DNLI 05-06-2025
- Dividend Yield
- KAR N/A
- DNLI N/A
- EPS Growth
- KAR N/A
- DNLI N/A
- EPS
- KAR 0.45
- DNLI N/A
- Revenue
- KAR $1,788,500,000.00
- DNLI N/A
- Revenue This Year
- KAR $1.43
- DNLI N/A
- Revenue Next Year
- KAR $6.78
- DNLI $373.37
- P/E Ratio
- KAR $44.22
- DNLI N/A
- Revenue Growth
- KAR 5.47
- DNLI N/A
- 52 Week Low
- KAR $15.44
- DNLI $12.05
- 52 Week High
- KAR $22.47
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- KAR 46.01
- DNLI 29.24
- Support Level
- KAR $18.87
- DNLI $13.67
- Resistance Level
- KAR $21.42
- DNLI $14.84
- Average True Range (ATR)
- KAR 0.67
- DNLI 0.81
- MACD
- KAR -0.15
- DNLI 0.03
- Stochastic Oscillator
- KAR 49.22
- DNLI 5.84
About KAR OPENLANE Inc.
Openlane Inc offers a digital marketplace for used vehicles. The services comprise financing, repossessions, repairs, transportation, warranty, and inventory services. It operates used-vehicle auctions and offers complete online services for all parties involved. The company has two operating segments which include Marketplace and Finance, of which it generates the majority of the revenue from the Marketplace segment.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.